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inpatient hospitalization, and post-transplant. The pre-
transplant section is presented by a transplant coordinator to
cover the necessary requirements prior to transplant. The
inpatient hospitalization and post-transplant phase are dis-
cussed by social work, nursing, dietary, and a senior physi-
cian assistant. The inpatient phase outlines patient
expectations, daily routine, conditioning and stem cell
transplant process, engraftment, low-microbial diet, and
possible complications of transplant. The post-transplant
phase emphasizes the necessity of a caregiver, transplant
precautions, frequency of follow up, and the recovery pro-
cess. Patients and caregivers have an opportunity to ask
general questions for each presenter.
Methods: Patients and caregivers were provided with a
Likert-scale questionnaire designed to gather feedback on
their feelings of preparation for the pre-transplant phase,
inpatient hospitalization, discharge process, complications,
post-transplant needs, and overall helpfulness of the group.
Data was collected from all groups over one year.
Findings & Interpretation: Results: 87 potential transplant
patients and caregivers completed the questionnaire. Par-
ticipants widely agreed that they felt more informed in all
aspects of transplant. 97% of group members agreed that the
overall group was helpful in preparing them for transplant.
Discussion & Implications: Conclusion: This interactive,
psychoeducational group proved to be a very effective
approach to best prepare patients and caregivers for trans-
plant.TRANSPLANT NURSING RESEARCH
606
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Topic Signiﬁcance & Study Purpose/Background/
Rationale: Patients with refractory hematological malig-
nancies are frequentlycandidates for life savingbutpotentially
life threatening treatment such as stem cell transplantation
(SCT). Thepurposeof this studywas todescribe themeaningof
the experience of SCT for African-American, Latino, and
Caucasian patients before, during and after SCT.
Methods, Intervention, & Analysis: Hermeneutic
phenomenological method was used to complete analysis of
data from interviews of 60 SCT patients that were conducted
before treatment began, at the time of blood count recovery,
and day 30, 60 and 100 after treatment.
Findings & Interpretation: “Like a bridge I never crossed
before” captured the meaning the experience had for par-
ticipants at all times. Three overlapping themes emerged:
Facing the Fear, Getting Through and Going Beyond, pri-
marily after the SCT. Contextual factors of life threatening
disease and treatment, lack of experience or knowledge,
emotional/coping, culture, symptom burden, and ﬁnancial
burden inﬂuenced the transition between the phases of SCT.
While the themes were common across all ethnicities dif-
ferences in emphasis were found.
Discussion & Implications: There is a need to determine the
meaning of SCT, its related education, and the experience ofbeing post treatment for patients and their families of all
ethnicities. Implications for practice include modifying care,
education, and planning to ensure patient centered care that
is responsive to the patient and family meanings. Research
that assesses such care and the related outcomes is essential.607
Engraftment in Sibling Allogeneic Stem Cell Transplant
Recipients Following the Change in Bone Marrow
Collection Devices
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Topic Signiﬁcance & Study Purpose/Background/
Rationale: The length of time between stem cell infusion
and engraftment can signiﬁcantly impact the recipient’s
survival and quality of life. We observed that the days until
engraftment in stem cell transplant recipients has increased
for unknown reasons. One possible explanation considered
was a change in bone marrow collection devices. In October
2009 the Baxter Fenwal P/N collection System was dis-
continued. We switched to a new device called the BioAccess
Marrow Collection System. This project investigatedwhether
the change in collection systems has impacted our patients’
time to engraftment after stem cell infusion.
Methods, Intervention, & Analysis: The number of days to
engraftment after stem cell transplant was evaluated by a
chart review of 67 patients that were transplanted at this
hospital between 2001 and 2014. The average days to
engraftment after collection using the Baxter Fenwal P/N
Collection System (before 10/2009) versus the BioAccess
Collection System (after 10/2009) were compared. All eval-
uated patients had received matched sibling donors trans-
plants with a conditioning regimen of Fractionated TBI (1320
cGy) with either Etoposide (60 mg/kg) or Busulfan (16 mg/
kg) and Cyclophosphamide (120 mg/kg). All subjects also
received GVHD prophylaxis with Cyclosporine and Metho-
trexate (15 mg/m2 on day +1 and 10 mg/m2 on days +3, +6,
+11).
Findings & Interpretation: Analysis of the data showed that
the mean days to engraftment for patients given cells
collected with the Baxter Fenwal P/N Collection System was
25.22 days with a standard deviation of 2.9. Patients given
cells collected with the BioAccess Collection System had a
mean engraftment time of 26.78 days with a standard de-
viation of 1.84. Further analysis with an unpaired T test
revealed that these results were statistically signiﬁcant, with
p¼0.01.
Discussion & Implications: This was a QA project to explore
possible causes for increased time to engraftment for our SCT
patients. The ﬁndings were found to be statistically signiﬁ-
cant. However, they didn’t show the clinical signiﬁcance
expected, as the means before and after the change in
collection devices only differed by one day. We therefore do
not see a need for changing our current bone marrow
collection system608
Removal of Chlorhexidine Gluconate-Impregnated
Dressings Due to Skin Irritation in Patients Under
Hematopoietic Stem Cell Transplantation
Bruna Nogueira Santos 1, Laís Carvalho Castanho 1,
Maria Carolina de Oliveira Rodrigues Physician 2,
Renata Cristina de Campos Pereira Silveira Professor 3.
Table 1
Description of the amount of interruptions in the use of CHXGID and of the
skin reactions presented.
6 dressings removed
4 deﬁnitively 2 temporarily
2- excoriated vesicles and skin
loss
1- skin loss
1- erythematous plaque and
excoriation
1 - microvesicles on skin in contact
with chlorhexidine gel
1 - superﬁcial skin desquamation
All patients, except for one, presented lesions on the skin in contact with the
Medipore high adhesion tape. Skin recovered four days later, on average.
The dressing was considered comfortable by four patients, and bearable by
two. The median intensity of pain reported during dressing replacement
was 6 (0 to 8.5). Five patients presented the skin lesions during the neu-
tropenia period and one presented the lesions after neutrophil engraftment.
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Topic Signiﬁcance & Study Purpose/Background/
Rationale: Describe reasons for removing chlorhexidine
gluconate-impregnated dressings (CHXGID), due to skin
irritation, in hematopoietic stem cell transplantation (HSCT).
Methods, Intervention, & Analysis: Patients treated with
allogeneic or autologous HSCT and using CHXGID on the site
of insertion of central venous catheters (CVCs) were pro-
spectively studied. For 45 days, dressings were daily moni-
tored to detect possible signs and symptoms of skin
irritation. Dressings were removed according to the exten-
sion and severity of the lesions. Patients daily estimated their
pain in a Numerical Rating Scale, from 0 to 10, with
0 meaning “no pain” and 10 “severe pain”. Tolerance to the
dressing was assessed daily by the following question: “How
do you feel about using this dressing?” with three options of
answers: “Comfortable”, “Bearable” or “Unbearable”.
Findings & Interpretation: A total of 25 patients were
evaluated from November 2013 to June 2014.
Discussion & Implications: Although poorly reported, the
development of skin lesions while in use of CHXGID is a
frequent problem in HSCT. Thus, the nurse must be alert to
detect signs and symptoms of skin irritation early caused by
the dressing and interrupt its use until recovery of skin
integrity. In these patients, rupture of the cutaneous barrier
is a concern, mainly due to their immunological vulner-
ability.
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Topic Signiﬁcance & Study Purpose/Background/
Rationale: Hematopoietic Stem Cell Transplantation (HSCT)
is a treatment option utilized for children and adolescents
with malignant and nonmalignant diseases. Anxiety, uncer-
tainty, and hope are commonly observed in those faced with
this treatment decision. The purpose of this integrative re-
view was to evaluate current literature on stakeholders’
perspectives on pursuing HSCT in children and adolescents
with malignant or nonmalignant diseases. The aim is toreview the literature speciﬁc to what inﬂuences those mak-
ing the decision to proceed with HSCT as a treatment mo-
dality; thus, donors are not included as stakeholders.
Methods, Intervention, & Analysis: Using standard inte-
grative review methods, we searched PubMed, CINAHL, and
MEDLINE databases with the following search terms:
hematopoietic stem cell transplantation, bone marrow
transplantation, decision-making, attitude, and decision. In-
clusion criteria consisted of research articles in the English
language published in peer-reviewed journals over the last
10 years; and at least one of the following stakeholder’s
perspectives: the pediatric patient, the parent and/or
guardian, and/or the pediatric provider. We excluded case
reports and articles pertaining only to adult patients or
providers. Sixteen articles met the criteria. The articles were
compared by disease type, stakeholder perspective, and
methodology.
Findings & Interpretation: Stakeholders pursuing HSCT for
a malignant disease often felt it was their only hope, while in
a nonmalignant disease a multitude of medical and psy-
chosocial factors were evident. Regardless of disease, all
stakeholders described uncertainty. Patients and family
members found provider opinion to be inﬂuential in their
decision, but few studies considered provider perspectives.
Experimental studies were lacking, as well as research of
actual decision-making experiences.
Discussion & Implications: Additional research is necessary
to better understand factors affecting the decision to pursue
HSCT in children and adolescents. Experimental studies are
essential to guide future decisional support and educational
intervention in this population. Inclusion of provider per-
spectives and actual versus hypothetical decision-making
experiences are also necessary in future studies.610
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Topic Signiﬁcance & Study Purpose/Background/
Rationale: Surveillance blood cultures aim maximum
reduction of unnecessary harm associated with health care.
Catheter-related bloodstream infections (CBSI) are a pre-
ventable problem, which should be considered when aiming
at patient safety. In this context, chlorhexidine gluconate-
impregnated dressings (CHXGID) are a current technology
that has been found favorable in the prevention of CBSI.
The present study aims to identify the occurrence of CBSI
during the use of CHXGID in patients under treatment with
hematopoietic stem cell transplantation (HSCT).
Methods, Intervention, & Analysis: Cross-sectional study
with patients who used CHXGID as coverage for the central
venous catheter. CBSI was conﬁrmed through the difference
higher than two hours in time of positivity between blood
cultures from the proximal and distal catheter ends or
through the presence of the same microorganism at the end
of the catheter and in the blood stream culture, besides
veriﬁcation of clinical infection at the exit site by means of
inspection and palpation.
